Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 427

1.

Cyclotriphosphazenes as Scaffolds for the Synthesis of Metallomesogens.

Jiménez J, Sanz JA, Serrano JL, Barberá J, Oriol L.

Inorg Chem. 2020 Mar 13. doi: 10.1021/acs.inorgchem.0c00124. [Epub ahead of print]

PMID:
32167295
2.

Global karst springs hydrograph dataset for research and management of the world's fastest-flowing groundwater.

Olarinoye T, Gleeson T, Marx V, Seeger S, Adinehvand R, Allocca V, Andreo B, Apaéstegui J, Apolit C, Arfib B, Auler A, Barberá JA, Batiot-Guilhe C, Bechtel T, Binet S, Bittner D, Blatnik M, Bolger T, Brunet P, Charlier JB, Chen Z, Chiogna G, Coxon G, De Vita P, Doummar J, Epting J, Fournier M, Goldscheider N, Gunn J, Guo F, Guyot JL, Howden N, Huggenberger P, Hunt B, Jeannin PY, Jiang G, Jones G, Jourde H, Karmann I, Koit O, Kordilla J, Labat D, Ladouche B, Liso IS, Liu Z, Massei N, Mazzilli N, Mudarra M, Parise M, Pu J, Ravbar N, Sanchez LH, Santo A, Sauter M, Sivelle V, Skoglund RØ, Stevanovic Z, Wood C, Worthington S, Hartmann A.

Sci Data. 2020 Feb 20;7(1):59. doi: 10.1038/s41597-019-0346-5.

3.

Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial Hypertension.

Callejo M, Mondejar-Parreño G, Esquivel-Ruiz S, Olivencia MA, Moreno L, Blanco I, Escribano-Subias P, Cogolludo A, Barbera JA, Perez-Vizcaino F.

J Clin Med. 2020 Feb 6;9(2). pii: E448. doi: 10.3390/jcm9020448.

4.

Does fibrosis really regress in HIV/hepatitis C virus co-infected patients after treatment with direct antiviral agents?

Rial-Crestelo D, Sepúlveda MA, González-Gasca FJ, Geijo-Martínez P, Martínez-Alfaro E, Barberá JR, Yzusqui M, Casallo S, García M, Hornero CM, Espinosa-Gimeno A, Torralba M.

AIDS. 2020 Mar 1;34(3):427-432. doi: 10.1097/QAD.0000000000002433.

PMID:
31996593
5.

Pulmonary hypertension in chronic obstructive pulmonary disease.

Gredic M, Blanco I, Kovacs G, Helyes Z, Ferdinandy P, Olschewski H, Barberà JA, Weissmann N.

Br J Pharmacol. 2020 Jan 23. doi: 10.1111/bph.14979. [Epub ahead of print] Review.

PMID:
31976545
6.

Portopulmonary hypertension: prognosis and management in the current treatment era. Results from the REHAP Registry.

Lázaro Salvador M, Quezada Loaiza CA, Rodríguez Padial L, Barberá JA, López-Meseguer M, López-Reyes R, Sala Llinas E, Alcolea S, Blanco I, Escribano Subías P; REHAP investigators.

Intern Med J. 2020 Jan 14. doi: 10.1111/imj.14751. [Epub ahead of print]

PMID:
31943676
7.

Impact of Nutrition on Pulmonary Arterial Hypertension.

Callejo M, Barberá JA, Duarte J, Perez-Vizcaino F.

Nutrients. 2020 Jan 7;12(1). pii: E169. doi: 10.3390/nu12010169. Review.

8.

The Top 50 Most Influential Articles in Hip Arthroscopy.

Barbera J, Selverian S, Courington R, Mikhail C, Colvin A.

Arthroscopy. 2020 Mar;36(3):716-722. doi: 10.1016/j.arthro.2019.09.031. Epub 2020 Jan 7.

PMID:
31919021
9.

Chronic Pulmonary Thromboembolic Disease.

Ramírez P, Otero R, Barberà JA.

Arch Bronconeumol. 2020 Jan 3. pii: S0300-2896(19)30587-3. doi: 10.1016/j.arbres.2019.10.027. [Epub ahead of print] Review. English, Spanish.

10.

An imported case of e-cigarette or vaping associated lung injury in Barcelona.

Casanova GS, Amaro R, Soler N, Sánchez M, Badía JR, Barberà JA, Agustí A.

Eur Respir J. 2020 Feb 6;55(2). pii: 1902076. doi: 10.1183/13993003.02076-2019. Print 2020 Feb. No abstract available.

PMID:
31806720
11.

Effects of Pulmonary Hypertension on Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease.

Blanco I, Valeiro B, Torres-Castro R, Barberán-García A, Torralba Y, Moisés J, Sebastián L, Osorio J, Rios J, Gimeno-Santos E, Roca J, Barberà JA.

Arch Bronconeumol. 2019 Nov 23. pii: S0300-2896(19)30407-7. doi: 10.1016/j.arbres.2019.10.015. [Epub ahead of print] English, Spanish.

12.

Does fibrosis really regress in HIV/HCV co-infected patients after treatment with direct-antiviral agents?

Rial-Crestelo D, Sepúlveda MA, González-Gasca FJ, Geijo-Martínez P, Martínez-Alfaro E, Barberá JR, Yzusqui M, Casallo S, García M, Hornero CM, Espinosa-Gimeno A, Torralba M.

AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002433. [Epub ahead of print]

PMID:
31764078
13.

Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.

McLaughlin VV, Vachiery JL, Oudiz RJ, Rosenkranz S, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Peacock AJ, Simonneau G, Rubin LJ, Blair C, Langley J, Hoeper MM; AMBITION Study Group.

J Heart Lung Transplant. 2019 Dec;38(12):1286-1295. doi: 10.1016/j.healun.2019.09.010. Epub 2019 Sep 17.

14.

Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension.

White RJ, Vonk-Noordegraaf A, Rosenkranz S, Oudiz RJ, McLaughlin VV, Hoeper MM, Grünig E, Ghofrani HA, Chakinala MM, Barberà JA, Blair C, Langley J, Frost AE.

Respir Res. 2019 Sep 12;20(1):208. doi: 10.1186/s12931-019-1180-1.

15.

Pulmonary vascular density: comparison of findings on computed tomography imaging with histology.

Rahaghi FN, Argemí G, Nardelli P, Domínguez-Fandos D, Arguis P, Peinado VI, Ross JC, Ash SY, de La Bruere I, Come CE, Diaz AA, Sánchez M, Washko GR, Barberà JA, San José Estépar R.

Eur Respir J. 2019 Aug 15;54(2). pii: 1900370. doi: 10.1183/13993003.00370-2019. Print 2019 Aug.

PMID:
31196942
16.

Therapeutic effects of soluble guanylate cyclase stimulation on pulmonary hemodynamics and emphysema development in guinea pigs chronically exposed to cigarette smoke.

Paul T, Blanco I, Aguilar D, Tura-Ceide O, Bonjoch C, Smolders VF, Peinado VI, Barberà JA.

Am J Physiol Lung Cell Mol Physiol. 2019 Aug 1;317(2):L222-L234. doi: 10.1152/ajplung.00399.2018. Epub 2019 Jun 5.

PMID:
31166128
17.

Progenitor cell mobilisation and recruitment in pulmonary arteries in chronic obstructive pulmonary disease.

Tura-Ceide O, Pizarro S, García-Lucio J, Ramírez J, Molins L, Blanco I, Torralba Y, Sitges M, Bonjoch C, Peinado VI, Barberà JA.

Respir Res. 2019 Apr 16;20(1):74. doi: 10.1186/s12931-019-1024-z.

18.

Genetic linkage analysis of a large family identifies FIGN as a candidate modulator of reduced penetrance in heritable pulmonary arterial hypertension.

Puigdevall P, Piccari L, Blanco I, Barberà JA, Geiger D, Badenas C, Milà M, Castelo R, Madrigal I.

J Med Genet. 2019 Jul;56(7):481-490. doi: 10.1136/jmedgenet-2018-105669. Epub 2019 Mar 20.

PMID:
30894412
19.

Metabolic Alterations in Cardiopulmonary Vascular Dysfunction.

Smolders VF, Zodda E, Quax PHA, Carini M, Barberà JA, Thomson TM, Tura-Ceide O, Cascante M.

Front Mol Biosci. 2019 Jan 22;5:120. doi: 10.3389/fmolb.2018.00120. eCollection 2018. Review.

20.

Despite Similar Perceptions and Attitudes, Postbaccalaureate Students Outperform in Introductory Biology and Chemistry Courses.

Shortlidge EE, Rain-Griffith L, Shelby C, Shusterman GP, Barbera J.

CBE Life Sci Educ. 2019 Mar;18(1):ar3. doi: 10.1187/cbe.17-12-0289.

21.

The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.

Newnham M, South K, Bleda M, Auger WR, Barberà JA, Bogaard H, Bunclark K, Cannon JE, Delcroix M, Hadinnapola C, Howard LS, Jenkins D, Mayer E, Ng C, Rhodes CJ, Screaton N, Sheares K, Simpson MA, Southwood M, Su L, Taboada D, Traylor M, Trembath RC, Villar SS, Wilkins MR, Wharton J, Gräf S, Pepke-Zaba J, Laffan M, Lane DA, Morrell NW, Toshner M.

Eur Respir J. 2019 Mar 28;53(3). pii: 1801805. doi: 10.1183/13993003.01805-2018. Print 2019 Mar.

22.

Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study.

Garcia-Lunar I, Pereda D, Santiago E, Solanes N, Nuche J, Ascaso M, Bobí J, Sierra F, Dantas AP, Galán C, San Antonio R, Sánchez-Quintana D, Sánchez-González J, Barberá JA, Rigol M, Fuster V, Ibáñez B, Sabaté M, García-Álvarez A.

Basic Res Cardiol. 2019 Jan 11;114(2):5. doi: 10.1007/s00395-018-0714-x.

PMID:
30635778
23.

ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.

Grünig E, Eichstaedt C, Barberà JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A, Delcroix M, de Man F, Gaine S, Ghio S, Gibbs S, Gumbiene L, Howard LS, Johnson M, Jurevičienė E, Kiely DG, Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, Olschewski H, Pepke-Zaba J, Reis A, Santos M, Saxer S, Tulloh RM, Ulrich S, Vonk Noordegraaf A, Peacock AJ.

Eur Respir J. 2019 Feb 28;53(2). pii: 1800332. doi: 10.1183/13993003.00332-2018. Print 2019 Feb.

PMID:
30578391
24.

Pulmonary hypertension in chronic lung disease and hypoxia.

Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, Weissmann N, Seeger W.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801914. doi: 10.1183/13993003.01914-2018. Print 2019 Jan.

25.

Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.

Vachiéry JL, Galiè N, Barberá JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Blair C, Miller KL, Langley J, Rubin LJ; AMBITION Study Group.

J Heart Lung Transplant. 2019 Feb;38(2):194-202. doi: 10.1016/j.healun.2018.11.006. Epub 2018 Nov 22.

26.

Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case-Control Study with Follow-up.

Borràs-Santos A, Garcia-Aymerich J, Soler-Cataluña JJ, Vigil Giménez L, Gea Guiral J, Rodríguez Chiaradía D, Pascual-Guardia S, Marcos Rodríguez PJ, Alvarez Martinez CJ, Casanova Macario C, López-Campos JL, Carrasco Hernández L, Martínez-González C, Santos-Pérez S, Peces-Barba G, Molina Paris J, Román Rodríguez M, Barberà JA, Faner R, Agustí A, Cosío BG; en representación del Grupo Investigador del estudio EARLY COPD.

Arch Bronconeumol. 2019 Jun;55(6):312-318. doi: 10.1016/j.arbres.2018.09.007. Epub 2018 Nov 11. English, Spanish.

PMID:
30429076
27.

Risk-stratified outcomes with initial combination therapy in pulmonary arterial hypertension: Application of the REVEAL risk score.

Frost AE, Hoeper MM, Barberá JA, Vachiery JL, Blair C, Langley J, Rubin LJ.

J Heart Lung Transplant. 2018 Dec;37(12):1410-1417. doi: 10.1016/j.healun.2018.07.001. Epub 2018 Sep 9.

PMID:
30209017
28.

Groundwater dynamics in a hydrologically-modified alpine watershed from an ancient managed recharge system (Sierra Nevada National Park, Southern Spain): Insights from hydrogeochemical and isotopic information.

Barberá JA, Jódar J, Custodio E, González-Ramón A, Jiménez-Gavilán P, Vadillo I, Pedrera A, Martos-Rosillo S.

Sci Total Environ. 2018 Nov 1;640-641:874-893. doi: 10.1016/j.scitotenv.2018.05.305. Epub 2018 Jun 5.

PMID:
29879673
29.

Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study.

Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Mayorga MI, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Casado A, Podzamczer D.

J Antimicrob Chemother. 2018 Aug 1;73(8):2171-2176. doi: 10.1093/jac/dky175.

PMID:
29788066
30.

[Results of the implementation of an Antimicrobial Stewardship Program in the "Gerencia de Atención Integrada" of Alcazar de San Juan (Castilla La Mancha)].

Asencio Egea MA, Herráez Carrera O, Huertas Vaquero M, Patiño Ortega HD, Franco Huerta M, Alcázar Carmona P, Conde García MC, Muñoz-Cuevas C, Román Ortiz C, Gaitán Pitera J, Carranza González R, Barberá JR.

Rev Esp Quimioter. 2018 Jun;31(3):247-256. Epub 2018 May 18. Spanish.

31.

[Monoclonal spread of multi-drug resistant CTX-M-15-producing Klebsiella pneumoniae. Impact of measures to control the outbreak].

Asencio Egea MA, Huertas Vaquero M, Muñoz-Cuevas C, Gaitán Pitera J, Herráez Carrera O, Alcázar Carmona P, Patiño Ortega HD, Franco Huerta M, Román Ortiz C, Conde García MC, Carranza González R, Barberá JR, Bautista Sánchez V.

Rev Esp Quimioter. 2018 Jun;31(3):237-246. Epub 2018 May 18. Spanish.

32.

MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling.

Musri MM, Coll-Bonfill N, Maron BA, Peinado VI, Wang RS, Altirriba J, Blanco I, Oldham WM, Tura-Ceide O, García-Lucio J, de la Cruz-Thea B, Meister G, Loscalzo J, Barberà JA.

Am J Respir Cell Mol Biol. 2018 Oct;59(4):490-499. doi: 10.1165/rcmb.2017-0040OC.

33.

Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?

Kovacs G, Agusti A, Barberà JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1000-1011. doi: 10.1164/rccm.201801-0095PP. Review. No abstract available.

PMID:
29746142
34.

Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease.

García-Lucio J, Peinado VI, de Jover L, Del Pozo R, Blanco I, Bonjoch C, Coll-Bonfill N, Paul T, Tura-Ceide O, Barberà JA.

PLoS One. 2018 Apr 19;13(4):e0195724. doi: 10.1371/journal.pone.0195724. eCollection 2018.

35.

Bilateral Neuropathy Dermatitis Following Simultaneous Bilateral Total Knee Arthroplasty: A Case Report.

Barbera J, van der Ven A, Amjad I.

JBJS Case Connect. 2018 Apr-Jun;8(2):e23. doi: 10.2106/JBJS.CC.17.00174.

PMID:
29642114
36.

Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: Highlights from basic research to therapy.

Huertas A, Guignabert C, Barberà JA, Bärtsch P, Bhattacharya J, Bhattacharya S, Bonsignore MR, Dewachter L, Dinh-Xuan AT, Dorfmüller P, Gladwin MT, Humbert M, Kotsimbos T, Vassilakopoulos T, Sanchez O, Savale L, Testa U, Wilkins MR.

Eur Respir J. 2018 Apr 4;51(4). pii: 1700745. doi: 10.1183/13993003.00745-2017. Print 2018 Apr. Review.

37.

Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations.

Barberà JA, Román A, Gómez-Sánchez MÁ, Blanco I, Otero R, López-Reyes R, Otero I, Pérez-Peñate G, Sala E, Escribano P.

Arch Bronconeumol. 2018 Apr;54(4):205-215. doi: 10.1016/j.arbres.2017.11.014. Epub 2018 Feb 19. English, Spanish.

PMID:
29472044
38.

The MINDVIEW project: First results.

Benlloch JM, González AJ, Pani R, Preziosi E, Jackson C, Murphy J, Barberá J, Correcher C, Aussenhofer S, Gareis D, Visvikis D, Bert J, Langstrom B, Farde L, Toth M, Haggkvist J, Caixeta FV, Kullander K, Somlai-Schweiger I, Schwaiger M.

Eur Psychiatry. 2018 Apr;50:21-27. doi: 10.1016/j.eurpsy.2018.01.002. Epub 2018 Feb 2.

PMID:
29398564
39.

Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching.

Chamorro V, Morales-Cano D, Milara J, Barreira B, Moreno L, Callejo M, Mondejar-Parreño G, Esquivel-Ruiz S, Cortijo J, Cogolludo Á, Barberá JA, Perez-Vizcaino F.

PLoS One. 2018 Jan 24;13(1):e0191239. doi: 10.1371/journal.pone.0191239. eCollection 2018.

40.

Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease.

Paul T, Salazar-Degracia A, Peinado VI, Tura-Ceide O, Blanco I, Barreiro E, Barberà JA.

PLoS One. 2018 Jan 5;13(1):e0190628. doi: 10.1371/journal.pone.0190628. eCollection 2018.

41.

Instrumental drift removal in GC-MS data for breath analysis: the short-term and long-term temporal validation of putative biomarkers for COPD.

Rodríguez-Pérez R, Cortés R, Guamán A, Pardo A, Torralba Y, Gómez F, Roca J, Barberà JA, Cascante M, Marco S.

J Breath Res. 2018 Mar 14;12(3):036007. doi: 10.1088/1752-7163/aaa492.

42.

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.

McLaughlin VV, Jansa P, Nielsen-Kudsk JE, Halank M, Simonneau G, Grünig E, Ulrich S, Rosenkranz S, Gómez Sánchez MA, Pulido T, Pepke-Zaba J, Barberá JA, Hoeper MM, Vachiéry JL, Lang I, Carvalho F, Meier C, Mueller K, Nikkho S, D'Armini AM.

BMC Pulm Med. 2017 Dec 28;17(1):216. doi: 10.1186/s12890-017-0563-7.

43.

Effectiveness of direct-acting antiviral therapy in patients with a HCV/HIV coinfection. A multicenter cohort study.

Rial-Crestelo D, Rodríguez-Cola M, González-Gasca FJ, Geijo-Martínez P, Belinchón-Moya O, Martínez-Alfaro E, Mateos-Rodríguez F, Barberá JR, Yzusqui M, Casallo S, García M, Espinosa-Gimeno A, Torralba M.

Rev Esp Enferm Dig. 2018 Jan;110(1):35-43. doi: 10.17235/reed.2017.5210/2017.

44.

An official European Respiratory Society statement: pulmonary haemodynamics during exercise.

Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, Garcia G, Grünig E, Howard L, Humbert M, Lau E, Laveneziana P, Lewis GD, Naeije R, Peacock A, Rosenkranz S, Saggar R, Ulrich S, Vizza D, Vonk Noordegraaf A, Olschewski H.

Eur Respir J. 2017 Nov 22;50(5). pii: 1700578. doi: 10.1183/13993003.00578-2017. Print 2017 Nov. Erratum in: Eur Respir J. 2018 Jan 18;51(1):.

45.

Mixed-Substituent Cyclophosphazenes with Calamitic and Polycatenar Mesogens.

Jiménez J, Callizo L, Serrano JL, Barberá J, Oriol L.

Inorg Chem. 2017 Jul 17;56(14):7907-7921. doi: 10.1021/acs.inorgchem.7b00612. Epub 2017 Jun 30.

PMID:
28665126
46.

Tablet computers and forensic and correctional psychological assessment: A randomized controlled study.

King CM, Heilbrun K, Kim NY, McWilliams K, Phillips S, Barbera J, Fretz R.

Law Hum Behav. 2017 Oct;41(5):468-477. doi: 10.1037/lhb0000245. Epub 2017 Jun 29.

PMID:
28661170
47.

Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.

Andrade-Campos M, Alfonso P, Irun P, Armstrong J, Calvo C, Dalmau J, Domingo MR, Barbera JL, Cano H, Fernandez-Galán MA, Franco R, Gracia I, Gracia-Antequera M, Ibañez A, Lendinez F, Madruga M, Martin-Hernández E, O'Callaghan MDM, Del Soto AP, Del Prado YR, Sancho-Val I, Sanjurjo P, Pocovi M, Giraldo P.

Orphanet J Rare Dis. 2017 May 3;12(1):84. doi: 10.1186/s13023-017-0627-z.

48.

Cigarette smoke challenges bone marrow mesenchymal stem cell capacities in guinea pig.

Tura-Ceide O, Lobo B, Paul T, Puig-Pey R, Coll-Bonfill N, García-Lucio J, Smolders V, Blanco I, Barberà JA, Peinado VI.

Respir Res. 2017 Mar 23;18(1):50. doi: 10.1186/s12931-017-0530-0.

49.

Hybrid photoluminescent materials containing a benzobisthiazole core for liquid crystal and gel applications.

Díaz E, Elgueta E, Sanchez SA, Barberá J, Vergara J, Parra M, Dahrouch M.

Soft Matter. 2017 Mar 1;13(9):1804-1815. doi: 10.1039/c6sm02650h.

PMID:
28169382
50.

Spectral analysis to assess exposure to extremely low frequency magnetic fields in cars.

Paniagua JM, Rufo M, Jiménez A, Antolín A, Barberá J.

Sci Total Environ. 2017 Apr 15;584-585:875-881. doi: 10.1016/j.scitotenv.2017.01.134. Epub 2017 Jan 31.

PMID:
28159308

Supplemental Content

Loading ...
Support Center